Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Alnylam Hopes For Strong hATTR Uptake For Vutrisiran With Longer Data
Jan 21 2022
•
By
Alaric DeArment
Alnylam presented 18-month data from the HELIOS-A study of vutrisiran in hATTR amyloidosis with polyneuropathy • Source: Shutterstock
More from Archive
More from Scrip